While the current study focuses on elucidating TRA’s cardioprotective effects through modulation of pyroptosis and the GPX3/Nrf2 axis, future work will systematically explore its regulatory roles in lipid metabolism and insulin signaling-two central pathogenic drivers of diabetic cardiomyopathy. The gene discussed is GPX3; the disease is diabetic cardiomyopathy.